Format

Send to

Choose Destination

See 1 citation in Clin J Am Soc Nephrol 2017:

Clin J Am Soc Nephrol. 2017 May 8;12(5):825-835. doi: 10.2215/CJN.05780616. Epub 2016 Nov 7.

Update on Lupus Nephritis.

Author information

1
Department of Internal Medicine, The Ohio State Wexner Medical Center, Columbus, Ohio.
2
Department of Internal Medicine, The Ohio State Wexner Medical Center, Columbus, Ohio Rovin.1@osu.edu.

Abstract

SLE is a chronic inflammatory disease that affects the kidneys in about 50% of patients. Lupus nephritis is a major risk factor for overall morbidity and mortality in SLE, and despite potent anti-inflammatory and immunosuppressive therapies still ends in CKD or ESRD for too many patients. This review highlights recent updates in our understanding of disease epidemiology, genetics, pathogenesis, and treatment in an effort to establish a framework for lupus nephritis management that is patient-specific and oriented toward maintaining long-term kidney function in patients with lupus.

KEYWORDS:

Chronic; Discoid; Epidemiology and outcomes; Lupus Erythematosus; Renal Insufficiency; Systemic; chronic; glomerular disease; glomerulonephritis; humans; immunosuppression; kidney; kidney failure; lupus nephritis; nephritis; risk factors; systemic lupus erythematosus

PMID:
27821390
PMCID:
PMC5477208
DOI:
10.2215/CJN.05780616
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center